Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (17095)	6/17/2005 7:25:55 AM
From: Robohogs	Read Replies (1) \| Respond to of 52153

Well at least CBST helps your charity portfolio. <g> But seriously, do you think the gains in CBST and OSCI hold? MNTA is different than the other two but the other 2 are playing off of the MICU deal and euphoria may fade. Jon

To: Biomaven who wrote (17095)	6/17/2005 3:11:07 PM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 52153

I'm prepared to go away on 3-day trips to the West coast more often if this is what they produce! MICU (moderate position), MNTA (good-sized position), OSCI (moderate position freshly added to) and the rest of the biotechs as well. Congratulations on your profitable holdings! But you might have bought GTCB, too, when I touted it on this board May 4 – it is up more than 80% since then. (May 4 was the date GTCB’s CEO announced in a webcast from Paris that the European regulators were coming to Massachusetts to inspect GTCB’s production facilities, which is usually one of the last steps before approval in the drug-review process.) Regards, Dew